Stonebridge Biopharma raises $35 million by selling shares at a deep discount
Stonebridge Biopharma PLC said Friday that it raised an expected $35 million by selling shares, and warrants to buy shares, at nearly a one-third discount. The biopharmaceutical company, based in Dublin, Ireland and Trevose, Penn., said it will issue 14 million shares to investors at $2.50 a share, and warrants to buy 7 million shares that are exercisable at $2.50 a share. The price is 31% below Thursday's closing price of $3.60. Stonebridge expects the placement of shares to close on or about Dec. Читать дальше...